Sao Vang Rubber JSC (HOSE:SRC)
28,300
-700 (-2.41%)
At close: Aug 5, 2025
ASLAN Pharmaceuticals Cash Flow Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 45,161 | 151,640 | 29,401 | 27,741 | 40,045 | 73,516 | Upgrade |
Depreciation & Amortization | 10,285 | 10,308 | 11,668 | 14,143 | 20,664 | 20,962 | Upgrade |
Loss (Gain) From Sale of Assets | - | -160,090 | - | -2,182 | - | 7,173 | Upgrade |
Other Operating Activities | -45,653 | -40,291 | -814.68 | -10,605 | -8,748 | -7,826 | Upgrade |
Change in Accounts Receivable | 44,841 | 44,754 | -204,074 | 5,454 | 525,235 | -603,201 | Upgrade |
Change in Inventory | -61,072 | -20,313 | 96,290 | -33,387 | -100,237 | 17,956 | Upgrade |
Change in Accounts Payable | -147,081 | -57,348 | -17,488 | 64,351 | -317,773 | 469,996 | Upgrade |
Change in Other Net Operating Assets | 383.79 | 2,581 | 2,705 | 4,428 | 3,854 | 5,370 | Upgrade |
Operating Cash Flow | -153,135 | -68,759 | -82,313 | 69,944 | 163,040 | -16,055 | Upgrade |
Operating Cash Flow Growth | - | - | - | -57.10% | - | - | Upgrade |
Capital Expenditures | -7,956 | -3,655 | -13,550 | -6,652 | -4,450 | -1,720 | Upgrade |
Sale of Property, Plant & Equipment | - | 300,800 | - | 2,182 | - | - | Upgrade |
Investment in Securities | - | - | - | - | -375,000 | - | Upgrade |
Other Investing Activities | 2,850 | 1,710 | 515.23 | 712.69 | 7,931 | 2,066 | Upgrade |
Investing Cash Flow | -106.01 | 298,854 | -13,035 | -3,757 | -287,911 | -78,384 | Upgrade |
Long-Term Debt Issued | - | 794,679 | 750,089 | 555,860 | 588,430 | 285,973 | Upgrade |
Long-Term Debt Repaid | - | -1,011,330 | -635,684 | -615,652 | -459,999 | -202,161 | Upgrade |
Net Debt Issued (Repaid) | 180,237 | -216,651 | 114,406 | -59,792 | 128,431 | 83,812 | Upgrade |
Common Dividends Paid | -33,573 | -16,795 | -22,380 | -16,784 | -27,976 | -22,383 | Upgrade |
Financing Cash Flow | 146,664 | -233,447 | 92,025 | -76,576 | 100,455 | 61,429 | Upgrade |
Foreign Exchange Rate Adjustments | 8.2 | 5.27 | -9.32 | -40.77 | -38.9 | -54.28 | Upgrade |
Net Cash Flow | -6,569 | -3,346 | -3,332 | -10,430 | -24,454 | -33,065 | Upgrade |
Free Cash Flow | -161,091 | -72,415 | -95,863 | 63,292 | 158,591 | -17,775 | Upgrade |
Free Cash Flow Growth | - | - | - | -60.09% | - | - | Upgrade |
Free Cash Flow Margin | -13.87% | -7.05% | -8.00% | 6.92% | 16.59% | -1.32% | Upgrade |
Free Cash Flow Per Share | -5740.27 | -2580.40 | -3415.96 | 2255.33 | 5651.16 | -633.40 | Upgrade |
Cash Interest Paid | 17,843 | 15,284 | 16,017 | 13,302 | 10,939 | 5,391 | Upgrade |
Cash Income Tax Paid | 11,396 | 71,051 | 6,991 | 13,892 | 13,552 | 25,099 | Upgrade |
Levered Free Cash Flow | -286,313 | 127,055 | -116,930 | 16,122 | 412,212 | -299,342 | Upgrade |
Unlevered Free Cash Flow | -275,053 | 136,649 | -106,923 | 24,516 | 419,039 | -295,912 | Upgrade |
Change in Net Working Capital | 304,514 | -100,595 | 140,642 | 13,961 | -368,525 | 372,365 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.